Ozempic-Linked Drug Semaglutide Trial Shows 52% Drop in Kidney Disease Markers – Is This the Next Big Breakthrough for CKD Patients?
Recent research shows that semaglutide (Ozempic®) can help patients with chronic kidney disease (CKD) and obesity, expanding its known benefits beyond diabetes treatment. The study, published in Nature Medicine, demonstrates substantial improvements
